Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Clinical Trial

Randomized Controlled Trial

Research Support, N.I.H., Extramural

Research Support, U.S. Gov't, Non-P.H.S.

Clinical Trial, Phase II

Validation Study

Clinical Trial, Phase I

Publication Year

From

Quick links

Individual year

2021

2019

2018

2017

2016

2015

2014

2013

2011

2004

2003

2001

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""HIV Core Protein p24""[mesh_terms]

15 Results

Searching titles within these results

Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides.

Anne-Marte B Kran, Tom Oystein Jonassen, Maja A Sommerfelt, Gunilla Løvgården, Birger Sørensen, Dag Kvale

AIDS (London, England) 2011;24(17):2609-18

Full Text

Abstract

Antigenicity of recombinant proteins after regioselective immobilization onto polyanhydride-based copolymers.

Laure Allard, Valérie Cheynet, Guy Oriol, Gaspard Gervasi, Emmanuelle Imbert-Laurenceau, Bernard Mandrand, Thierry Delair, François Mallet

Bioconjugate chemistry 2004;15(3):458-66

Full Text

Abstract

Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors.

Matteo Surdo, Maria Francesca Cortese, Chiara Orlandi, Fabiola Di Santo, Stefano Aquaro, Mauro Magnani, Carlo Federico Perno, Anna Casabianca, Francesca Ceccherini-Silberstein

Antiviral research 2019;160():165-174

Full Text

Abstract

Graph-based optimization of epitope coverage for vaccine antigen design.

James Theiler, Bette Korber

Statistics in medicine 2018;37(2):181-194

Free Full Text

Abstract

Impact of HIV-1 Membrane Cholesterol on Cell-Independent Lytic Inactivation and Cellular Infectivity.

Ramalingam Venkat Kalyana Sundaram, Huiyuan Li, Lauren Bailey, Adel A Rashad, Rachna Aneja, Karl Weiss, James Huynh, Arangaserry Rosemary Bastian, Elisabeth Papazoglou, Cameron Abrams, Steven Wrenn, Irwin Chaiken

Biochemistry 2016;55(3):447-58

Free Full Text

Abstract

Computational prediction of anti HIV-1 peptides and in vitro evaluation of anti HIV-1 activity of HIV-1 P24-derived peptides.

Naghmeh Poorinmohammad, Hassan Mohabatkar, Mandana Behbahani, Davood Biria

Journal of peptide science : an official publication of the European Peptide Society 2015;21(1):10-6

Full Text

Abstract

Pulsed stable isotope labeling of amino acids in cell culture uncovers the dynamic interactions between HIV-1 and the monocyte-derived macrophage.

Stephanie D Kraft-Terry, Ian L Engebretsen, Dhundy K Bastola, Howard S Fox, Pawel Ciborowski, Howard E Gendelman

Journal of proteome research 2011;10(6):2852-62

Free Full Text

Abstract

Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire.

Nicholas J Steers, Jeffrey R Currier, Gustavo H Kijak, Robert C di Targiani, Ashima Saxena, Mary A Marovich, Jerome H Kim, Nelson L Michael, Carl R Alving, Mangala Rao

Journal of virology 2011;85(4):1541-53

Free Full Text

Abstract

Analytical Advances in the Ex Vivo Challenge Efficacy Assay.

Nicola Richardson-Harman, Robert Parody, Peter Anton, Ian McGowan, Gustavo Doncel, Andrea Ries Thurman, Carolina Herrera, Kattayoun Kordy, Julie Fox, Karen Tanner, Glenn Swartz, Charlene S Dezzutti

AIDS research and human retroviruses 2017;33(4):395-403

Free Full Text

Abstract

T cell responses to recall antigens, alloantigen, and mitogen of HIV-infected patients receiving long-term combined antiretroviral therapy.

V Blazevic, N Sahgal, H A Kessler, A L Landay, G M Shearer

AIDS research and human retroviruses 2001;16(17):1887-93

Full Text

Abstract

Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years.

Andreas Lind, Maja Sommerfelt, Jens Olof Holmberg, Ingebjørg Baksaas, Birger Sørensen, Dag Kvale

Scandinavian journal of infectious diseases 2013;44(8):566-72

Full Text

Abstract

Long-term intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed.

Y K Cho, H Sung, H J Lee, C H Joo, G J Cho

International immunopharmacology 2001;1(7):1295-1305

Full Text

Abstract

Phase I trial of a therapeutic HIV type 1 vaccine, Vacc-4x, in HIV type 1-infected individuals with or without antiretroviral therapy.

Birgitta Asjö, Helen Stavang, Birger Sørensen, Ingebjørg Baksaas, Jørgen Nyhus, Nina Langeland

AIDS research and human retroviruses 2003;18(18):1357-65

Full Text

Abstract

Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis.

J Gerstoft, T L Katzenstein, C Camara, C Wejse, A Furtado, M Lüneborg-Nielsen, M Sodemann

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2014;17(10):e907-12

Free Full Text

Abstract

Domain-Scan: Combinatorial Sero-Diagnosis of Infectious Diseases Using Machine Learning.

Smadar Hada-Neeman, Yael Weiss-Ottolenghi, Naama Wagner, Oren Avram, Haim Ashkenazy, Yaakov Maor, Ella H Sklan, Dmitry Shcherbakov, Tal Pupko, Jonathan M Gershoni

Frontiers in immunology 2021;11():619896

Free Full Text

Abstract

Results: 1 – 15 / 15

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""HIV Core Protein p24""[mesh_terms]

Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides.

Antigenicity of recombinant proteins after regioselective immobilization onto polyanhydride-based copolymers.

Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors.

Graph-based optimization of epitope coverage for vaccine antigen design.

Impact of HIV-1 Membrane Cholesterol on Cell-Independent Lytic Inactivation and Cellular Infectivity.

Computational prediction of anti HIV-1 peptides and in vitro evaluation of anti HIV-1 activity of HIV-1 P24-derived peptides.

Pulsed stable isotope labeling of amino acids in cell culture uncovers the dynamic interactions between HIV-1 and the monocyte-derived macrophage.

Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire.

Analytical Advances in the Ex Vivo Challenge Efficacy Assay.

T cell responses to recall antigens, alloantigen, and mitogen of HIV-infected patients receiving long-term combined antiretroviral therapy.

Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years.

Long-term intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed.

Phase I trial of a therapeutic HIV type 1 vaccine, Vacc-4x, in HIV type 1-infected individuals with or without antiretroviral therapy.

Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis.

Domain-Scan: Combinatorial Sero-Diagnosis of Infectious Diseases Using Machine Learning.

Results for
""HIV Core Protein p24""[mesh_terms]